SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-21-012607
Filing Date
2021-03-12
Accepted
2021-03-11 18:08:03
Documents
90
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K sndx-10k_20201231.htm   iXBRL 10-K 3681560
2 EX-10.14 sndx-ex1014_191.htm EX-10.14 63267
3 EX-23.1 sndx-ex231_9.htm EX-23.1 2334
4 EX-31.1 sndx-ex311_8.htm EX-31.1 11681
5 EX-31.2 sndx-ex312_10.htm EX-31.2 11698
6 EX-32.1 sndx-ex321_6.htm EX-32.1 11103
7 GRAPHIC gzafwpdcckfu000001.jpg GRAPHIC 134855
8 GRAPHIC gzafwpdcckfu000002.jpg GRAPHIC 40230
  Complete submission text file 0001564590-21-012607.txt   12510916

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA sndx-20201231.xsd EX-101.SCH 76785
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sndx-20201231_cal.xml EX-101.CAL 65374
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sndx-20201231_def.xml EX-101.DEF 241904
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE sndx-20201231_lab.xml EX-101.LAB 582731
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sndx-20201231_pre.xml EX-101.PRE 432198
14 EXTRACTED XBRL INSTANCE DOCUMENT sndx-10k_20201231_htm.xml XML 2224221
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37708 | Film No.: 21734614
SIC: 2834 Pharmaceutical Preparations